Undoubtedly, the past two years have changed the pharma industry forever; new modalities are dominating pharma pipelines, drugs are increasing in potency, and the restrictions around product quality are tighter than ever before.

It is integral that the HPAPI community comes together to apply expertise in ensuring operator safety, alongside product quality, to the future of hazardous drug production and fully understand this new landscape, and regulatory environment. Built in collaboration with industry experts, the HPAPI Summit provides end-to end coverage tackling; development, commercial manufacturing & tech transfer, occupational toxicology, industrial hygiene & EHS, across small molecules, large molecules, drug conjugates & ATMP, for a holistic approach to bullet-proofing your hazardous drug production.

With sessions championed from the likes of Merck, Bayer, AstraZeneca, Takeda and more, don’t miss this opportunity to reconnect, reassess and re-enforce your risk management for your potent pipeline and production at the longest standing and largest global summit for highly potent API’s & hazardous drugs.

Save up to $700 on your event pass when you book before Friday, May 20.

Group discounts of up to 20% are also available when you bring your team!

To know more visit: https://ter.li/3csco9